{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:44:56Z","timestamp":1791852296708,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2004670"],"award-info":[{"award-number":["GNT2004670"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1176574"],"award-info":[{"award-number":["GNT1176574"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cell.2025.06.023","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:45:24Z","timestamp":1752576324000},"page":"4896-4912.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo"],"prefix":"10.1016","volume":"188","author":[{"given":"James P.","family":"Cooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Hirons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Jansz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody C.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis E.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Dagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumana","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yurick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Arandjelovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie M.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reet","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Mackiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Dayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Clow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey J.","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Einsiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian F.J.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Doerflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.06.023_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v16101616","article-title":"Current State of Therapeutics for HTLV-1","volume":"16","author":"Wang","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2025.06.023_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2015.09.004","article-title":"How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)?","volume":"14","author":"Bangham","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02563","article-title":"Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM\/TSP","volume":"8","author":"Enose-Akahata","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.06.023_bib5","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.06.023_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009915","article-title":"Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey","volume":"15","author":"Einsiedel","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-3366-5","article-title":"Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study","volume":"16","author":"Einsiedel","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cell.2025.06.023_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu023","article-title":"Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study","volume":"1","author":"Einsiedel","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/mja16.00285","article-title":"The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community","volume":"205","author":"Einsiedel","year":"2016","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.cell.2025.06.023_bib12","doi-asserted-by":"crossref","first-page":"00001","DOI":"10.1183\/23120541.00001-2019","article-title":"Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study","volume":"5","author":"Einsiedel","year":"2019","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.cell.2025.06.023_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006281","article-title":"Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians","volume":"12","author":"Einsiedel","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib14","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1093\/cid\/ciaa1401","article-title":"Pulmonary Disease Is Associated With Human T-Cell Leukemia Virus Type 1c Infection: A Cross-sectional Survey in Remote Aboriginal Communities","volume":"73","author":"Einsiedel","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib15","article-title":"T-lymphocyte alveolitis in HTLV-I-associated myelopathy","volume":"2","author":"Sugimoto","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.06.023_bib16","article-title":"Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection","volume":"18","author":"Einsiedel","year":"2021","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-019-0502-1","article-title":"Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence","volume":"16","author":"Sarkis","year":"2019","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-024-00647-w","article-title":"High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia","volume":"21","author":"Hirons","year":"2024","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.06.023_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.cell.2025.06.023_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13070553","article-title":"High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London Experience","volume":"13","author":"Taylor","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.cell.2025.06.023_bib22","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2025.06.023_bib23","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1128\/AAC.46.9.3080-3083.2002","article-title":"Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro","volume":"46","author":"Balestrieri","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2025.06.023_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/AAC.00470-07","article-title":"Effect of phosphonated carbocyclic 2\u2032-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro","volume":"52","author":"Balestrieri","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2025.06.023_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01877","article-title":"Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors","volume":"10","author":"Barski","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/v3050469","article-title":"Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors","volume":"3","author":"Macchi","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2025.06.023_bib27","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1128\/JVI.01009-06","article-title":"De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice","volume":"80","author":"Miyazato","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00278","article-title":"How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy","volume":"9","author":"Pasquier","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial","volume":"3","author":"Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib30","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0140-6736(24)00295-2","article-title":"Why not eliminate HTLV-1 while eliminating HIV-1?","volume":"403","author":"Maertens","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.06.023_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/cid\/ciu227","article-title":"Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002\u20132012","volume":"59","author":"Hewagama","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2013.11.003","article-title":"HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection","volume":"26","author":"Bangham","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.06.023_bib34","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib35","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","article-title":"Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent","volume":"21","author":"Hirons","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib36","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.1005256107","article-title":"BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs","volume":"107","author":"Carrington","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.06.023_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak","volume":"315","author":"Willis","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.06.023_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004458","article-title":"HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation","volume":"10","author":"Choi","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2025.06.023_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/vim.2020.0131","article-title":"Intrinsic and Extrinsic Cell Apoptotic Pathways in Patients with HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis: A Systematic Review","volume":"34","author":"Bastos Ferreira","year":"2021","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cell.2025.06.023_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","article-title":"Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples","volume":"96","author":"Nicot","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.06.023_bib41","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2025.06.023_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2011.11.030","article-title":"Targeting Bcl-2 family proteins in adult T-cell leukemia\/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737","volume":"317","author":"Ishitsuka","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2025.06.023_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ijc.29726","article-title":"HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression","volume":"138","author":"Witzens-Harig","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cell.2025.06.023_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-014-2530-9","article-title":"Mechanism-based pharmacokinetic\/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia","volume":"74","author":"Kaefer","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cell.2025.06.023_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102514","article-title":"Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice","volume":"10","author":"Esp\u00edndola","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cell.2025.06.023_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00565-19","article-title":"Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice","volume":"93","author":"Galli","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02147","article-title":"HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact","volume":"10","author":"Pinto","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009559","article-title":"Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth","volume":"15","author":"Springer","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2013-06-508861","article-title":"An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity","volume":"123","author":"Tezuka","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.06.023_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002231","article-title":"HTLV-1 propels thymic human T cell development in \"human immune system\" Rag2\u207b\/\u207b gamma c\u207b\/\u207b mice","volume":"7","author":"Villaudy","year":"2011","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.cell.2025.06.023_bib51","first-page":"3701","article-title":"Induction of APOBEC3B cytidine deaminase in HTLV-1-infected humanized mice","volume":"17","author":"Yao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cell.2025.06.023_bib52","article-title":"Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice","volume":"4","author":"Arandjelovic","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.cell.2025.06.023_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cell.2025.06.023_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib55","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type 1","volume":"64","author":"Richardson","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib56","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s13365-020-00881-w","article-title":"Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"26","author":"Nozuma","year":"2020","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.cell.2025.06.023_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-385524-4.00004-0","article-title":"Adult T cell leukemia\/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1","volume":"111","author":"Bangham","year":"2011","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.cell.2025.06.023_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1532\/IJG97.06002","article-title":"Delineation of immunoregulatory properties of adult T-cell leukemia cells","volume":"84","author":"Matsubar","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cell.2025.06.023_bib59","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.06.023_bib60","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/503874","article-title":"Reduced Foxp3 Protein Expression Is Associated with Inflammatory Disease during Human T Lymphotropic Virus Type 1 Infection","volume":"193","author":"Oh","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003630","article-title":"HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression","volume":"9","author":"Yamamoto-Taguchi","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2025.06.023_bib62","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaci.2015.12.1314","article-title":"IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis","volume":"138","author":"Humblet-Baron","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cell.2025.06.023_bib63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","article-title":"The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach","volume":"29","author":"Katsuya","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2025.06.023_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01063-18","article-title":"Multiplex Droplet Digital PCR Assay for Quantification of Human T-Cell Leukemia Virus Type 1 Subtype c DNA Proviral Load and T Cells from Blood and Respiratory Exudates Sampled in a Remote Setting","volume":"57","author":"Yurick","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019826","article-title":"Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells","volume":"6","author":"Danner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2025.06.023_bib66","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2010-08-301507","article-title":"Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2R\u03b3(null) humanized mice","volume":"117","author":"Billerbeck","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.06.023_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/v8020041","article-title":"A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I","volume":"8","author":"Fujii","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2025.06.023_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-015-0236-7","article-title":"Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients","volume":"13","author":"Cook","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.cell.2025.06.023_bib69","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/cid\/cit547","article-title":"Editorial commentary: lessons on transplant-acquired human T-cell lymphotropic virus infection","volume":"57","author":"Taylor","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib70","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/21.4.992","article-title":"Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia\/lymphoma during immunosuppressive treatment following renal transplantation","volume":"21","author":"Jenks","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJM199002083220607","article-title":"Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation","volume":"322","author":"Gout","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.06.023_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1970","article-title":"Human T-lymphotropic virus type 1 infection and solid organ transplantation","volume":"28","author":"Taylor","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/519167","article-title":"Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor","volume":"196","author":"Cassar","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002418","article-title":"Human T-cell lymphotropic virus type 1 subtype C molecular variants among indigenous australians: new insights into the molecular epidemiology of HTLV-1 in Australo-Melanesia","volume":"7","author":"Cassar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib75","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1128\/jvi.67.2.1015-1023.1993","article-title":"Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions","volume":"67","author":"Gessain","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0377-4929.94870","article-title":"HTLV 1 associated adult T cell lymphoma\/leukemia a clinicopathologic, immunophenotypic tale of three cases from non-endemic region of south India","volume":"55","author":"Ahmed","year":"2012","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.cell.2025.06.023_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/v10120691","article-title":"Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases","volume":"10","author":"Futsch","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2025.06.023_bib78","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1378\/chest.124.6.2283","article-title":"High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders","volume":"124","author":"Yamazato","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cell.2025.06.023_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.08.012","article-title":"HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP","volume":"304","author":"Yamano","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cell.2025.06.023_bib80","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jmv.23307","article-title":"Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement","volume":"84","author":"Kawabata","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cell.2025.06.023_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/thx.2004.021667","article-title":"Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers","volume":"60","author":"Mori","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.cell.2025.06.023_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005560","article-title":"CADM1\/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis","volume":"12","author":"Manivannan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2025.06.023_bib84","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/cas.14219","article-title":"CD4(+) CADM1+ cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia\/lymphoma","volume":"110","author":"Makiyama","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2025.06.023_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.06.023_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2005.09.001","article-title":"Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia\/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro","volume":"68","author":"Balestrieri","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2025.06.023_bib86","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/322785","article-title":"Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine","volume":"184","author":"Garc\u00eda-Lerma","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib87","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/AAC.47.5.1774-1775.2003","article-title":"Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V-->I) of the reverse transcriptase","volume":"47","author":"Toro","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2025.06.023_bib88","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41418-020-0498-z","article-title":"Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells","volume":"27","author":"Teh","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2025.06.023_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1002-0","article-title":"High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease","volume":"15","author":"Honarbakhsh","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cell.2025.06.023_bib90","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008730","article-title":"Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation","volume":"5","author":"Silke","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102263","article-title":"Killing in self-defense: proapoptotic drugs to eliminate intracellular pathogens","volume":"79","author":"Schaefer","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cell.2025.06.023_bib92","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2025.06.023_bib93","article-title":"NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS","volume":"217","author":"Louis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2025.06.023_bib94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acs.jproteome.5b00981","article-title":"Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies","volume":"15","author":"Lazar","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cell.2025.06.023_bib95","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2025.06.023_bib96","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1074\/mcp.TIR119.001646","article-title":"DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cell.2025.06.023_bib97","series-title":"R. A language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.cell.2025.06.023_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2025.06.023_bib99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","article-title":"Orchestrating single-cell analysis with Bioconductor","volume":"17","author":"Amezquita","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2025.06.023_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-019-1662-y","article-title":"EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data","volume":"20","author":"Lun","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib101","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","article-title":"Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R","volume":"33","author":"McCarthy","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2025.06.023_bib102","article-title":"Pooling across cells to normalize single-cell RNA sequencing data with many zero counts","volume":"17","author":"Lun","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib103","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/bioinformatics\/btv088","article-title":"Identification of cell types from single-cell transcriptomes using a novel clustering method","volume":"31","author":"Xu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2025.06.023_bib104","first-page":"1","article-title":"The Igraph Software Package for Complex Network Research","volume":"1695","author":"Csardi","year":"2006","journal-title":"Int. J."},{"key":"10.1016\/j.cell.2025.06.023_bib105","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","article-title":"Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.06.023_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13059-021-02581-y","article-title":"Universal prediction of cell cycle position using transfer learning","volume":"23","author":"Zheng","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib107","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2025.06.023_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/srep39921","article-title":"Batch effects and the effective design of single-cell gene expression studies","volume":"7","author":"Tung","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2025.06.023_bib109","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-4939-3578-9_19","article-title":"It's DE-licious: A Recipe for Differential Expression Analyses of RNA-seq Experiments Using Quasi-Likelihood Methods in edgeR","volume":"1418","author":"Lun","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib110","doi-asserted-by":"crossref","DOI":"10.1515\/1544-6115.1826","article-title":"Detecting Differential Expression in RNA-sequence Data Using Quasi-likelihood with Shrunken Dispersion Estimates","volume":"11","author":"Lund","year":"2012","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.cell.2025.06.023_bib111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","article-title":"Testing significance relative to a fold-change threshold is a TREAT","volume":"25","author":"McCarthy","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425006890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425006890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T21:08:12Z","timestamp":1767820092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867425006890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":111,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0092867425006890"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.06.023","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}